Please login to the form below

Not currently logged in


This page shows the latest Plegridy news and features for those working in and with pharma, biotech and healthcare.

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

In 2014, Plegridy was initially approved in the US for relapsing forms of MS, to be administered via subcutaneous (SC) injection every 14 days. ... In addition, the results showed that participants receiving Plegridy through IM administration experienced

Latest news

More from news
Approximately 7 fully matching, plus 10 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...